Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools […]
Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
In the pulsating heart of Japan’s biomedical sector, two fields have steadily crystallized their dominance – […]